A preliminary study on metallo-β-lactamase producing Pseudomonas aeruginosa in hospitalized patients

Indian Journal of Medical Research

Volumn 116, Issue DEC., 2002, Pages 264-267

  Navaneeth, B V ^a   Sridaran, D ^b   Sahay, D ^b   Belwadi, M R S ^b  

^a KING ABDUL AZIZ SPECIALIST HOSPITAL   (Saudi Arabia)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

Metallo lactamase; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; MERCAPTOETHANOL; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULPERAZON; TAZOBACTAM; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIFFUSION; EARLY DIAGNOSIS; ENZYME SYNTHESIS; HOSPITAL PATIENT; HUMAN; INDIA; INFECTION CONTROL; NONHUMAN; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; SCREENING TEST;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; HOSPITALIZATION; HUMANS; INDIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0038179413     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, et al. Multifocal outbreaks of metallo-β-lactamase producing Pseudomonas aeruginosa resistant to broad spectrum-β-lactans, including carbapenems. Antimicrob Agents Chemother 1996; 40: 349-53.
2. Woodford N, Palepou M-F I, Babini GS, Bates J. Livermore DM. Carbapenemase-producin Pseudomona aueuginosa in UK. Lancet 1998; 352: 546-7.
3. Poirel L, Naas T, Nicolas D, Collet L, Bellais S. Cavallo JD, et al. Characterization of VIM-2. A carbapenem-hydrolyzing metallo- β-lactamase and its plasmid and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother 2000; 44: 891-7.
4. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo- β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45: 2224-8.
5. Ambler RP. The structure of β-lacatamses. Philos Trans R Soc Lond B Biol Sci 1980; 289: 321-31.
6. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
7. Goto M, Takahashi T, Yamashita F, Koreeda A, Mori H. Ohta M, et al. Inhibition of the metallo-β-lactamase produced from Serratia marcescens by thiol compounds. Biol Pharm Bull 1997; 20: 1136-40.
8. Busk K. Metallo-β-lactamases: A class apart. Clin Infect Dis 1998; 27 (Suppl 1) S48-53.
9. Govan JRW. Pseudomonas, Stenotrophomonas, Burkholderia. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology, 14th ed. Edinburgh: Churchill Livingstone 1996 p. 413-24.
10. Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 1984; 311: 560-4.
11. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a stadardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
12. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fugiwara H, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38: 40-3.
13. National Committee for Clinical Laboratory Standards. Methods for dilution of antimicrobial suceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards. Wayne. Pa. 1997. Approved standard M7-A4.
14. Hancock REW. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria. Clin Infect Dis 1998; 27 (Suppl 1): S93-9.
15. Livermore DM. Interplay of impermeability and chromosomal β-lactamase activity in imipenem resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36: 2046-8.
16. Matsumura N, Minami S, Watanabe Y, Iyobe S, Mitsuhashi S. Role of permeability in the activities of β-lactams against Gram negative bacteria which produce a group 3 β-lactamase. Antimicrob Agents Chemother 1999; 43: 2084-6.
17. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43: 1584-90.
18. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 2000: 44: 1229-35.
19. Iyobe S, Kusadokoro H, Ozaki J, Matsumura N, Minami S, Haruta S, et al. Amino acid substitutions in a varient of IMP-1 metallop-β-lactamase. Antimicrob Agents Chemother 2000; 44: 2023-7.